Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes

被引:50
作者
Kawasaki, T
Ogata, N
Akanuma, H
Sakai, T
Watanabe, H
Ichiyanagi, K
Yamanouchi, T
机构
[1] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 1730003, Japan
[2] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2004年 / 53卷 / 05期
关键词
D O I
10.1016/j.metabol.2003.12.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to investigate the association of fructose on microangiopathy in patients with diabetes. Postprandial plasma fructose concentrations and postprandial plasma glucose concentrations were simultaneously measured 3 times within a 24-hour period (2 hours after each meal) in 38 patients with type 2 diabetes that had been admitted to the hospital. The mean postprandial plasma fructose concentrations (MPPF) and the mean postprandial plasma glucose concentrations (MPPG) were calculated. Fructose was measured by gas chromatography-mass spectrometry (GCMS). Based solely on MPPF, we were able to divide the patients into three groups: the high MPPF (31.9 +/- 6.5 mumol/L) group (n = 12), the middle MPPF (21.2 +/- 1.8 mumol/L) group (n = 13), and the low MPPF (15.2 +/- 2.4 mumol/L) group (n = 13). Prevalence and degree of retinopathy and nephropathy were then evaluated in the 3 different groups. A significant correlation was observed in the prevalence of proliferative diabetic retinopathy (PDR) among the 3 MPPF groups (P =.024). The prevalence of PDR was higher in the high MPPF group (75.0%) than in the middle and low MPPF groups (23.1% and 38.5%, respectively). Although not significantly different statistically, the prevalence of all degrees of retinopathy showed a tendency to be higher in the high MPPF group (83.3%) than in the middle and low MPPF groups (46.2% and 46.2%, respectively) (P =.081). Nephropathy prevalence also showed a tendency to be higher in the high MPPF group (66.7%) than in the middle and low MPPF groups (38.5% and 30.8%, respectively), although the differences were not significant. The prevalence of clinical albuminuria was not significantly different among the 3 groups, but there was a tendency for it to be higher in the low MPPF group (30.8%) than in the high and middle MPPF groups (16.7% and 0%, respectively). No significant differences in glycemic indicators and mean duration of diabetes were observed among the 3 groups. The increased prevalence of retinopathy in the high MPPF group suggests that fructose is associated with retinopathy in patients with type 2 diabetes.(C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 20 条
[1]   RETINOPATHY AND NEPHROPATHY IN INSULIN-DEPENDENT DIABETICS - AN INCONSISTENT RELATIONSHIP [J].
AGARDH, E ;
TALLROTH, G ;
BAUER, B ;
CAVALLINSJOBERG, U ;
AGARDH, CD .
DIABETIC MEDICINE, 1987, 4 (03) :248-250
[2]   Epalrestat, an aldose reductase inhibitor, reduces the levels of Nε-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients [J].
Hamada, Y ;
Nakamura, J ;
Naruse, K ;
Komori, T ;
Kato, K ;
Kasuya, Y ;
Nagai, R ;
Horiuchi, S ;
Hotta, N .
DIABETES CARE, 2000, 23 (10) :1539-1544
[3]  
HAYWARD LD, 1977, CARBOHYD RES, V53, P13
[4]   INCREASE IN CARDIAC-MUSCLE FRUCTOSE CONTENT IN STREPTOZOTOCIN-INDUCED DIABETIC RATS [J].
KASHIWAGI, A ;
OBATA, T ;
SUZAKI, M ;
TAKAGI, Y ;
KIDA, Y ;
OGAWA, T ;
TANAKA, Y ;
ASAHINA, T ;
IKEBUCHI, M ;
SAEKI, Y ;
KIKKAWA, R ;
SHIGETA, Y .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (10) :1041-1046
[5]  
Kawasaki T, 2003, DIABETES, V52, pA549
[6]   Increased fructose concentrations in blood and urine in patients with diabetes [J].
Kawasaki, T ;
Akanuma, H ;
Yamanouchi, TY .
DIABETES CARE, 2002, 25 (02) :353-357
[7]   The Wisconsin epidemiologic study of diabetic retinopathy: XVII - The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes [J].
Klein, R ;
Klein, BEK ;
Moss, SE ;
Cruickshanks, KJ .
OPHTHALMOLOGY, 1998, 105 (10) :1801-1815
[8]   The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors [J].
Ko, GTC ;
Chan, JCN ;
Woo, J ;
Lau, E ;
Yeung, VTF ;
Chow, CC ;
Cockram, CS .
ANNALS OF CLINICAL BIOCHEMISTRY, 1998, 35 :62-67
[9]   ENERGY-EXPENDITURE AND SUBSTRATE METABOLISM AFTER ORAL FRUCTOSE IN PATIENTS WITH CIRRHOSIS [J].
KRUSZYNSKA, YT ;
MEYERALBER, A ;
WOLLEN, N ;
MCINTYRE, N .
JOURNAL OF HEPATOLOGY, 1993, 19 (02) :241-251
[10]   Diabetic retinopathy, visual acuity, and medical risk indicators -: A continuous 10-year follow-up study in Type 1 diabetic patients under routine care [J].
Lövestam-Adrian, M ;
Agardh, CD ;
Torffvit, O ;
Agardh, E .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (06) :287-294